• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  
• Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
  

PubMed=11261825; DOI=10.1023/A:1006461422273
Steven J. Santner, Peter J. Dawson, Larry Tait, Herbert D. Soule, James F. Eliason, Anwar N. Mohamed, Sandra R. Wolman, Gloria H. Heppner, Fred R. Miller;
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.
Breast Cancer Res. Treat. 65:101-110(2001)

PubMed=15375546; DOI=10.3892/ijo.25.4.961
Xin-Jian Peng, Du-Ri Yun, Konstantin Christov;
Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Int. J. Oncol. 25:961-971(2004)

PubMed=20169162; DOI=10.1371/journal.pone.0009201; PMCID=PMC2821407
Mitsutaka Kadota, Howard H. Yang, Bianca P. Gomez, Misako Sato, Robert J. Clifford, Daoud Meerzaman, Barbara Karen Dunn, Lalage M. Wakefield, Maxwell P. Lee;
Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
PLoS ONE 5:e9201.1-e9201.10(2010)

PubMed=24262153; DOI=10.1016/j.jprot.2013.11.006; PMCID=PMC3920745
Ten-Yang Yen, Nicole Haste, Leslie C. Timpe, Christina Litsakos-Cheung, Roger Yen, Bruce A. Macher;
Using a cell line breast cancer progression system to identify biomarker candidates.
J. Proteomics 96:173-183(2014)